Processa Pharmaceuticals Inc (PCSA)
1.04
-0.03
(-2.80%)
USD |
NASDAQ |
Nov 14, 12:21
Processa Pharmaceuticals Price to Book Value: 0.5623 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.5785 |
| November 12, 2024 | 0.5785 |
| November 11, 2024 | 0.5948 |
| November 08, 2024 | 0.5948 |
| November 07, 2024 | 0.6218 |
| November 06, 2024 | 0.6056 |
| November 05, 2024 | 0.5948 |
| November 04, 2024 | 0.6001 |
| November 01, 2024 | 0.6218 |
| October 31, 2024 | 0.6245 |
| October 30, 2024 | 0.7191 |
| October 29, 2024 | 0.7299 |
| October 28, 2024 | 0.7299 |
| October 25, 2024 | 0.7083 |
| October 24, 2024 | 0.7029 |
| October 23, 2024 | 0.7299 |
| October 22, 2024 | 0.7245 |
| October 21, 2024 | 0.7624 |
| October 18, 2024 | 0.757 |
| October 17, 2024 | 0.7137 |
| October 16, 2024 | 0.7191 |
| October 15, 2024 | 0.6704 |
| October 14, 2024 | 0.6704 |
| October 11, 2024 | 0.7083 |
| October 10, 2024 | 0.6813 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.6867 |
| October 08, 2024 | 0.6813 |
| October 07, 2024 | 0.6704 |
| October 04, 2024 | 0.6434 |
| October 03, 2024 | 0.7083 |
| October 02, 2024 | 0.7191 |
| October 01, 2024 | 0.7185 |
| September 30, 2024 | 0.7407 |
| September 27, 2024 | 0.7407 |
| September 26, 2024 | 0.6976 |
| September 25, 2024 | 0.7191 |
| September 24, 2024 | 0.7234 |
| September 23, 2024 | 0.7352 |
| September 20, 2024 | 0.7353 |
| September 19, 2024 | 0.7407 |
| September 18, 2024 | 0.7678 |
| September 17, 2024 | 0.7678 |
| September 16, 2024 | 0.784 |
| September 13, 2024 | 0.7245 |
| September 12, 2024 | 0.7245 |
| September 11, 2024 | 0.7083 |
| September 10, 2024 | 0.7083 |
| September 09, 2024 | 0.7191 |
| September 06, 2024 | 0.6921 |
| September 05, 2024 | 0.7135 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4762
Minimum
May 31 2024
16.21
Maximum
Dec 15 2020
2.717
Average
1.974
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9236 |
| Theriva Biologics Inc | 0.0543 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| Price | 1.04 |
| Earnings Yield | -519.2% |
| Market Cap | 3.387M |